comparemela.com

Latest Breaking News On - Extensive stage small cell lung cancer es sclc - Page 1 : comparemela.com

FDA Approves Drug To Protect Against Chemo-Induced Myelosuppression

US FDA approved trilaciclib to offer protection against chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer (ES-SCLC).

Drug-administration
Myelosuppression
Trilaciclib
Chemotherapy
Extensive-stage-small-cell-lung-cancer-es-sclc
Chemotherapy-induced-myelosuppression
கீமோதெரபி

vimarsana © 2020. All Rights Reserved.